Core signal
What: Summarizes age-specific ADHD management recommendations from the AAP and NICE guidelines.
PRO Summary
How to read this card
Evidence scope
Ages 4–5 (preschool): Both AAP and NICE recommend evidence-based behavioral therapy (parent training) as the first-line approach. Medication is considered when behavioral therapy is insufficiently effective or functional impairment persists (AAP). NICE recommends a second specialist opinion before prescribing medication for children under 5.
Use principle
Ages 6+ (school-age): AAP recommends medication alongside behavioral therapy as the first-line approach. NICE recommends combined pharmacological and non-pharmacological treatment.
Evidence Reading
What to check when interpreting the evidence
Study typeType: ClinicalPracticeGuideline (AAP 2019 + NICE NG87)
PopulationTarget: Children with ADHD (ages 4–18)
EvidenceGrade: A
UseAges 6+ (school-age): AAP recommends medication alongside behavioral therapy as the first-line approach. NICE recommends combined pharmacological and non-pharmacological treatment.
Consultation Prep
Turn the card into questions before consultation
Be aware that guidelines recommend different first-line approaches by age. This does not mean one treatment is "better" — it reflects which approaches have accumulated more consistent evidence for each age group.
Record this as a question or context point before professional consultation.
For children aged 4–5, you can ask the specialist, "Can we start with behavioral therapy (parent training)?"
Record this as a question or context point before professional consultation.
Even for children 6+, ask about combining behavioral therapy with medication.
Record this as a question or context point before professional consultation.
Ask the specialist, "What does the guideline recommend as the first-line approach for my child's age?"
Record this as a question or context point before professional consultation.
Limits
PRO use principles
Evidence scope
Limitations: AAP and NICE guidelines are based on US and UK healthcare systems and may differ from local healthcare environments. Directly applying this content to other settings may not be appropriate. Age cutoffs are general recommendations — the best approach varies by individual.
Hold individual application
Do not transfer group-level findings or review summaries directly to an individual case without considering family context, school context, comorbidity, and professional guidance.
Use principle
Disclaimer: This summary is for informational purposes only. Actual treatment decisions should be made in consultation with a qualified physician. Guidelines may vary by country.
Professional consultation
Diagnosis, treatment, medication, educational planning, and ADHD management should be discussed with qualified professionals.
Scope Note
Notice and limits
Limitations: AAP and NICE guidelines are based on US and UK healthcare systems and may differ from local healthcare environments. Directly applying this content to other settings may not be appropriate. Age cutoffs are general recommendations — the best approach varies by individual.
Disclaimer: This summary is for informational purposes only. Actual treatment decisions should be made in consultation with a qualified physician. Guidelines may vary by country.